Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02399488
Other study ID # CEIC:47/10
Secondary ID
Status Recruiting
Phase N/A
First received March 22, 2015
Last updated August 16, 2015
Start date February 2012
Est. completion date September 2015

Study information

Verified date August 2015
Source Hospital Universitario Doctor Peset
Contact Juan Soliveres, MD, PhD
Phone +34670758871
Is FDA regulated No
Health authority Spain: Comité Ético de Investigación Clínica
Study type Observational

Clinical Trial Summary

Continuous haemoglobin determination could improve the outcomes of several patients in risk of bleeding during surgery. An in vivo calibration has been introduced to the device after our team found its need. The uncalilbrated validation of the Masimo Radical 7 continuous haemoglobin monitor has been made in various papers, although it has been compared to point of care devices, thus introducing an error as such point of care devices although validated for haemoglobin determination, are not as accurate as the gold standard. The validation of the gold standard calibrated device has not been described yet.

When compared to the accepted gold standard (cyanmethemoglobin method, Coulter), accuracy and precision of the continuous haemoglobin monitor could be good enough to be used interchangeably with the gold standard.


Description:

Continuous haemoglobin determination could improve the outcomes of several patients in risk of bleeding during surgery.

The in vivo calibration has not been adjusted to the gold standard haemoglobin determination in the literature yet.

Two blood samples will be withdrawn at the same time from an arterial line, one for the central laboratory and the other one for the POC device. At the same exact time the SpHb measurement will be recorded. At least eight samples are expected per patient. A maximum of 20 samples will be withdrawn per patient.

To compare bias, precision and limits of agreement among SpHb, LabHb and COoxHb the Bland Altman method will be used with multiple observations per subject when the true value varies. An error grid analysis will be made to know how it could affect to clinical decision making.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date September 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients.

- Surgery duration of at least two hours.

- Patients scheduled to surgery under general anaesthesia and muscle relaxation.

- Radial arterial line needed for blood pressure control or other reason not related to the study.

Exclusion Criteria:

- Radial arterial line not indicated / not possible to place.

- Sampling difficult or impossible.

- Need to reposition arterial line arm during surgery.

- Any illness that could influence the haemoglobin measurement.

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Sphb Haemoglobin in Vivo Validation

Intervention

Device:
Masimo Radical 7
Simultaneous determination of haemoglobin with the continuous haemoglobin monitor, the central lanboratory coulter and a POC:

Locations

Country Name City State
Spain University Hospital Doctor Peset Valencia

Sponsors (1)

Lead Sponsor Collaborator
Hospital Universitario Doctor Peset

Country where clinical trial is conducted

Spain, 

References & Publications (1)

Soliveres J, Balaguer J, Estruch M, Sánchez A, Sánchez J. Validation of Continuous and Noninvasive Hemoglobin Monitoring from Pulse CO-Oximetry during Surgery. 2010 Annual Meeting of the American Society Anesthesiologists

Outcome

Type Measure Description Time frame Safety issue
Other Comparison of bias and limits of agreement Comparison of bias and limits of agreement among central laboratory, POC cooximeter and SpHb continuous monitor. 3 months No
Other Clinical decision making Error grid analysis plot 3 months No
Primary Central coulter bias and limits of agreement Bias and limits of agreement of SpHb compared to the central laboratory coulter 3 months No
Primary Central coulter bias and limits of agreement after in vivo calibration Bias and limits of agreement of SpHb compared to the central laboratory coulter after in vivo Radical 7 calibration 3 months No
Secondary POC Cooximeter bias and limits of agreement Bias and limits of agreement of SpHb compared to the POC cooximeter 3 months No
Secondary POC Cooximeter bias and limits of agreement Bias and limits of agreement compared to the POC cooximeter after in vivo Radical 7 calibration 3 months No
Secondary POC Cooximeter Coulter interchangeability Bias and limits of agreement of POC Cooximeter Hb determination compared to the central laboratory coulter 3 months No

External Links